Evelo Biosciences, Inc.
EVLODelisted Dec 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001694665
Evelo Biosciences, Inc. was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Nov 8, 2023; 29 institutions reported holding it in 13F filings for Q3 2023, worth $52.0M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Evelo Biosciences, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +3 vs. Q3 2022
- Shares held
- 87.0M
- +906.1K (+1.1%) vs. Q3 2022
- Total value
- $140.1M
- −$39.9M (−22.2%) vs. Q3 2022
- New holders
- 9
- 15 more added
- Sold out
- 6
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVLO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $2.63K |
| Q3 2023 | 29 | $52.0M |
| Q2 2023 | 25 | $11.3M |
| Q1 2023 | 39 | $15.5M |
| Q4 2022 | 44 | $140.1M |
| Q3 2022 | 41 | $180.0M |
| Q2 2022 | 46 | $180.4M |
| Q1 2022 | 68 | $161.1M |
| Q4 2021 | 66 | $290.1M |
| Q3 2021 | 64 | $331.6M |
| Q2 2021 | 66 | $645.4M |
| Q1 2021 | 62 | $508.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Evelo Biosciences, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Flagship Pioneering Inc. | 50,427,328 | $81.2M | 2.59% | 00.0% | Unchanged |
| FMR LLC | 16,428,351 | $26.4M | 0.00% | +229,296+1.4% | Added |
| State of Michigan Retirement System | 4,070,728 | $6.55M | 0.05% | 00.0% | Unchanged |
| Credit Suisse AG | 3,678,388 | $5.92M | 0.01% | +8,210+0.2% | Added |
| Vanguard Group Inc | 3,168,375 | $5.10M | 0.00% | −54,045−1.7% | Reduced |
| HarbourVest Partners LLC | 3,063,505 | $4.93M | 1.65% | 00.0% | Unchanged |
| CVI Holdings, LLC | 1,471,572 | $2.37M | 0.30% | −222,083−13.1% | Reduced |
| BlackRock Inc. | 1,232,681 | $1.98M | 0.00% | +27,315+2.3% | Added |
| Alphabet Inc. | 1,060,495 | $1.71M | 0.10% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 607,443 | $977.0K | 0.00% | +20,960+3.6% | Added |
| Mayo Clinic | 479,242 | $771.6K | 0.41% | +479,242 | New |
| State Street Corp | 152,129 | $244.9K | 0.00% | +38,271+33.6% | Added |
| Susquehanna International Group, LLP | 146,059 | $235.2K | 0.00% | +128,086+712.7% | Added |
| Trustees of Columbia University in the City of New York | 113,850 | $183.0K | 0.38% | +113,850 | New |
| Bridgeway Capital Management, LLC | 105,300 | $169.5K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 99,625 | $160.4K | 0.00% | +93,485+1,522.6% | Added |
| Northern Trust Corp | 94,970 | $152.9K | 0.00% | −302−0.3% | Reduced |
| Millennium Management LLC | 93,841 | $151.0K | 0.00% | −90,822−49.2% | Reduced |
| 683 Capital Management, LLC | 90,291 | $145.4K | 0.01% | +90,291 | New |
| Morgan Stanley | 78,892 | $127.0K | 0.00% | +14,567+22.6% | Added |
| Bessemer Group Inc | 61,289 | $99.0K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 52,699 | $84.8K | 0.00% | +52,699 | New |
| Man Group plc | 52,637 | $84.7K | 0.00% | +52,637 | New |
| Charles Schwab Investment Management Inc | 31,345 | $50.5K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 31,336 | $50.5K | 0.00% | −2,729−8.0% | Reduced |
| Qube Research & Technologies Ltd | 29,537 | $47.6K | 0.00% | +9,860+50.1% | Added |
| Barclays PLC | 22,641 | $36.5K | 0.00% | +19,639+654.2% | Added |
| Bank of America Corp | 19,279 | $31.0K | 0.00% | −29,427−60.4% | Reduced |
| Shay Capital LLC | 18,511 | $29.8K | 0.02% | +18,511 | New |
| Bank of New York Mellon Corp | 13,150 | $21.2K | 0.00% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 10,135 | $16.3K | 0.00% | +10,135 | New |
| Citadel Advisors LLC | 9,952 | $16.0K | 0.00% | +9,952 | New |
| Tower Research Capital LLC (TRC) | 5,320 | $9.00K | 0.00% | +35+0.7% | Added |
| UBS Group AG | 4,564 | $7.35K | 0.00% | +1,952+74.7% | Added |
| JPMorgan Chase & Co | 3,534 | $6.00K | 0.00% | −3,674−51.0% | Reduced |
| BNP Paribas Arbitrage, SA | 1,553 | $2.50K | 0.00% | +905+139.7% | Added |
| Advisor Group Holdings, Inc. | 1,500 | $2.00K | 0.00% | +1,500 | New |
| China Universal Asset Management Co., Ltd. | 1,113 | $1.79K | 0.00% | +102+10.1% | Added |
| Fairfield Financial Advisors, LTD | 1,075 | $1.73K | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 739 | $1.19K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 390 | $628 | 0.00% | +10+2.6% | Added |
| National Bank of Canada | 100 | $160 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 14 | $0 | 0.00% | −130−90.3% | Reduced |
| Daiwa Securities Group Inc. | 156 | $0 | 0.00% | 00.0% | Unchanged |
| Ergoteles LLC | 0 | $0 | 0.00% | −27,429−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,346−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Cresset Asset Management, LLC | 0 | $0 | 0.00% | −18,366−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −11,082−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −10,833−100.0% | Sold out |